BJDX Stock Summary and Trading Ideas (Bluejay Diagnostics | NASDAQ:BJDX)

Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.

Bluejay Diagnostics trades on the NASDAQ stock market under the symbol BJDX.

As of April 24, 2026, BJDX stock price declined to $1.90 with 6,263 million shares trading.

BJDX has a beta of -0.50, meaning it tends to be less sensitive to market movements. BJDX has a correlation of 0.00 to the broad based SPY ETF.

BJDX has a market cap of $1.96 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, BJDX traded as high as $22,367.84 and as low as $1.65.

BJDX has underperformed the market in the last year with a return of -71.1%, while the SPY ETF gained +31.9%. In the last 3 month period, BJDX fell short of the market, returning -42.1%, while SPY returned +3.8%. However, in the most recent 2 weeks BJDX has outperformed the stock market by returning +6.7%, while SPY returned +5.1%.

BJDX support price is $1.82 and resistance is $2.10 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BJDX shares will trade within this expected range on the day.